| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/22/2007 | CA2524619A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/22/2007 | CA2242562C Human dnase resistant to actin inhibition |
| 05/22/2007 | CA2182274C Antigenic preparation for treatment or prevention of helicobacter infection |
| 05/22/2007 | CA2143187C Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/22/2007 | CA2111645C Fibrinogen fragment e peptides and antibodies thereto |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/22/2007 | CA2100559C Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/22/2007 | CA2073045C A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/18/2007 | WO2007056536A1 Glioma-specific antibodies against behab/brevican for diagnostic and therapeutic applications |
| 05/18/2007 | WO2007056507A1 Human bnp immunospecific antibodies |
| 05/18/2007 | WO2007056470A2 Neuropilin antagonists |
| 05/18/2007 | WO2007056411A2 Method of producing pan-specific antibodies |
| 05/18/2007 | WO2007056288A2 Methods of evaluating baff |
| 05/18/2007 | WO2007056047A2 Antibodies, assays and kits to quantitate cartilage destruction |
| 05/18/2007 | WO2007055684A2 Determining security realm identity before permitting network connection |
| 05/18/2007 | WO2007055602A1 Methods and compositions for the assessment of cardiovascular function and disorders |
| 05/18/2007 | WO2007055369A1 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 05/18/2007 | WO2007055340A1 Method of measuring ptx3 with high sensitivity |
| 05/18/2007 | WO2007055284A1 Method for stabilization of biological molecule and composition |
| 05/18/2007 | WO2007054809A2 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 05/18/2007 | WO2007054120A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | WO2007054103A1 Immunoglobulin and fatty acids |
| 05/18/2007 | WO2007054090A1 Therapeutic vaccines targeting hmgb1 |
| 05/18/2007 | WO2007053956A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | WO2007053952A1 Platelet factor-4 (pf-4) analogs and their use |
| 05/18/2007 | WO2007033140A3 Prok2 antagonists and methods of use |
| 05/18/2007 | WO2007007160A3 Anti-madcam antibodies to treat fever |
| 05/18/2007 | WO2007007151A3 Use of anti-mad-cam antibody for the treatment of emphysema |
| 05/18/2007 | WO2007007086A3 Antibodies for anthrax |
| 05/18/2007 | WO2007001420A3 Isolating human antibodies |
| 05/18/2007 | WO2006132907A3 Methods of treating, diagnosing or detecting cancer using an ephb3 modulator |
| 05/18/2007 | WO2006116657A3 Single-chain antibody with cleavable linker |
| 05/18/2007 | WO2006116609A3 Methods for treating lower motor neuron diseases and compositions for the same |
| 05/18/2007 | WO2006017538A3 Hk1-binding proteins |
| 05/18/2007 | WO2005111066A8 Polypeptides from non-typeable haemophilus influenzae |
| 05/18/2007 | WO2005072126A3 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/18/2007 | WO2003077872A3 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 05/18/2007 | CA2630023A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | CA2629438A1 Human bnp immunospecific antibodies |
| 05/18/2007 | CA2629388A1 Methods and compositions for the assessment of cardiovascular function and disorders |
| 05/18/2007 | CA2629125A1 Glioma-specific antibodies against behab/brevican for diagnostic and therapeutic applications |
| 05/18/2007 | CA2629028A1 Neuropilin antagonists |
| 05/18/2007 | CA2628552A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | CA2628546A1 Therapeutic vaccines targeting hmgb1 |
| 05/18/2007 | CA2626859A1 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| 05/18/2007 | CA2626831A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 05/17/2007 | US20070113303 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 05/17/2007 | US20070112180 Detection of biomolecules by sensitizer-linked substrates |
| 05/17/2007 | US20070112179 Novel compounds |
| 05/17/2007 | US20070112178 contacting the solution with a chromatography resin containing a support to which multi-modal ligands have been immobilised ( N-hydroxysuccinimide activated agarose carrier coupled with 3-amino-4(propylsulfonyl)thiophene-2-carboxylic acid ligand) to adsorb antibodies and/or contaminants to the resin |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111931 Compositions and methods for promoting wound healing and tissue repair |
| 05/17/2007 | US20070111282 Immunoglobulins; antibodies; complementary determining regions; immunoassay |
| 05/17/2007 | US20070111281 Antigen binding molecules having modified Fc regions and altered binding to Fc receptors |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070111261 Antigens |
| 05/17/2007 | US20070111260 A system for whole antibody cell surface display on mammalian cells to facilitate the rapid identification of antibodies with modified Fc regions having altered effector function |
| 05/17/2007 | US20070111255 Antibodies recognizing methyllysine, process for producing the same and utilization thereof |
| 05/17/2007 | US20070111254 Bioaffinity assay for quantitative determination of pregnancy associated plasma protein A (PAPP-A); detecting cardiovascular disorders |
| 05/17/2007 | US20070111252 Alcadeins and amyloid precursor protein co-localization for use as evaluative and prognostic tools in monitoring dementia and nervous system degeneration |
| 05/17/2007 | US20070111214 20685, 579,17114, 23821, 33894 and 32613, novel human transporters |
| 05/17/2007 | US20070110771 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens |
| 05/17/2007 | US20070110766 Proteinase K resistant surface protein of neisseria meningitidis |
| 05/17/2007 | US20070110757 Antibody formulations having optimized aggregation and fragmentation profiles |
| 05/17/2007 | US20070110755 Vascular endothelial cell growth factor antagonists |
| 05/17/2007 | US20070110754 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 05/17/2007 | US20070110753 Therapeutic agents for solid tumors |
| 05/17/2007 | US20070110750 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 05/17/2007 | US20070110748 Fibronectin binding protein compositions and methods of use |
| 05/17/2007 | US20070110747 Binding agents |
| 05/17/2007 | US20070110746 Pharmaceutical composition for treatment of immunological disorders |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110743 Methods of protein production using anti-senescence compounds |
| 05/17/2007 | US20070110733 Compositions and methods for stem cell delivery |
| 05/16/2007 | EP1785487A2 Polypeptides involved in the expression of resistance to glycopeptide antibiotics |
| 05/16/2007 | EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/16/2007 | EP1785434A1 Targeting and tracing of antigens in living cells |
| 05/16/2007 | EP1784643A2 Homogeneous enzyme immunoassay for oral fluid |
| 05/16/2007 | EP1784491A2 Method for improved transgene expression |
| 05/16/2007 | EP1784427A2 Bispecific fusion antibodies with enhanced serum half-life |
| 05/16/2007 | EP1784426A2 Humanized anti-beta7 antagonists and uses therefor |
| 05/16/2007 | EP1784425A2 Anti-mcp-1 antibodies, compositions, methods and uses |
| 05/16/2007 | EP1784424A2 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 05/16/2007 | EP1784221A2 Methods for the treatment and prevention of infection using anti-selectin agents |
| 05/16/2007 | EP1784219A2 Stabilizing formulations |
| 05/16/2007 | EP1784216A1 S100 protein inhibitors for treating leukemia |
| 05/16/2007 | EP1784209A1 Contraceptives based on sp22 and sp22 antibodies |
| 05/16/2007 | EP1490407B1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
| 05/16/2007 | EP1487981B1 Growth regulating proteins |
| 05/16/2007 | EP1465923B1 Corticotropin releasing factor receptor 2 agonists |
| 05/16/2007 | EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization |
| 05/16/2007 | EP1263790B1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 05/16/2007 | EP1185664B1 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF |
| 05/16/2007 | EP1172436B1 Ceramidase gene |
| 05/16/2007 | EP1165603B1 Human neurogenin 3-encoding nucleotide sequences |
| 05/16/2007 | EP1132468B1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 05/16/2007 | EP1129190B1 Human tslp dna and polypeptides |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | CN1965082A 人源化抗体 Humanized antibodies |
| 05/16/2007 | CN1964990A Antibodies specific for glycoprotein VI and methods of producing these antibodies |